Valuation: Getinge AB

Market Cap 64.82B 0 6.63B 5.74B 5.43B 4.92B 9.23B 636B 9.3B 24.94B 323B 24.91B 24.36B 1,029B P/E 2026 *
20.5x
P/E 2027 * 18.4x
Enterprise Value 73.03B 0 7.47B 6.47B 6.12B 5.54B 10.4B 717B 10.48B 28.09B 363B 28.06B 27.44B 1,159B EV / Sales 2026 *
2.07x
EV / Sales 2027 * 1.9x
Free-Float
79.13%
Yield 2026 *
2.17%
Yield 2027 * 2.36%
1 week-4.72%
Current month-5.61%
1 month-3.81%
3 months+18.82%
6 months+17.44%
Current year+3.06%
1 week 20.2
Extreme 20.2
21
1 month 20.2
Extreme 20.2
21.6
Manager TitleAgeSince
Chief Executive Officer 54 01/05/2017
Director of Finance/CFO 48 31/03/2024
Compliance Officer 47 01/10/2020
Director TitleAgeSince
Chairman 65 23/04/2019
Chairman 75 -
Director/Board Member 70 01/01/2007
Change 5-day change 1-year change 3-year change Capi.($)
+1.98%-4.72%+5.76% - 6.64B
-0.33%-0.10%+21.21%+19.19% 12.6B
+0.04%-0.63%+12.36%+18.81% 6.64B
+1.50%-4.55% - - 6.18B
+0.06%-4.94%+20.93%+9.00% 5.58B
-1.23%+0.98%-18.28%+42.04% 5.15B
+2.24%+2.04%-33.26%-23.26% 3.78B
+1.51%-2.34%+29.36%-14.74% 1.89B
0.00%+4.81%-1.29%+187.06% 1.77B
+1.60%-2.25%+48.32%-16.80% 1.59B
Average +0.60%-1.81%+9.46%+27.66% 5.02B
Weighted average by Cap. +0.28%-1.79%+9.08%+21.08%

Financials

2026 *2027 *
Net sales 35.26B 0 3.61B 3.12B 2.95B 2.68B 5.02B 346B 5.06B 13.57B 175B 13.55B 13.25B 560B 37.24B 0 3.81B 3.3B 3.12B 2.83B 5.3B 365B 5.34B 14.33B 185B 14.31B 13.99B 591B
Net income 3.17B 0 324M 281M 265M 240M 451M 31.07B 454M 1.22B 15.75B 1.22B 1.19B 50.24B 3.53B 0 361M 313M 296M 268M 502M 34.61B 506M 1.36B 17.55B 1.36B 1.33B 55.97B
Net Debt 8.2B 0 839M 727M 687M 622M 1.17B 80.49B 1.18B 3.16B 40.81B 3.15B 3.08B 130B 5.96B 0 610M 528M 499M 452M 848M 58.47B 855M 2.29B 29.65B 2.29B 2.24B 94.55B
Logo Getinge AB
Getinge AB is a Sweden-based company operating within healthcare sector. The Company provides hospitals and Life Science institutions with products and solutions aimed at improving clinical outcomes and optimizing workflows. The Company’s reporting segments have the following activities: Acute Care Therapies develops solutions for life-sustaining care in acute health conditions. Life Science offers a comprehensive range of equipment, technical expertise and prevention consultation contamination in pharmaceutical production, biomedical research, production of medical equipment and in various laboratory applications. Surgical Workflows offers products and services for the effective disinfection and sterilization of instruments used in operations, operating tables and others hardware for operating rooms and advanced IT systems for efficient and secure workflows in hospitals.
Employees
-
Date Price Change
15/09/26 PTS 20.60 +1.98%
14/09/26 PTS 20.20 -0.98%
11/09/26 PTS 20.40 -1.92%
10/09/26 PTS 20.80 0.00%
09/09/26 PTS 20.80 -0.95%
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
11
Last Close Price
238.00SEK
Average target price
247.60SEK
Spread / Average Target
+4.03%

Quarterly revenue - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!